OA02.04 Phase 1/2 Randomized Trial of Anetumab Ravtansine and Pembrolizumab Compared to Pembrolizumab for Pleural Mesothelioma - NCT03126630
Mansfield, A.S., Yin, J.V., Bradbury, P., Kwiatkowski, D., Patel, S., Bazhenova, L., Forde, P., Lou, Y., Villaruz, L., Arnold, S., Khalil, M., Kindler, H., Koczywas, M., Pacheco, J., Rolfo, C., Xia, B., Mikula, E.R., Sharon, E., Moscow, J., Hassan, R.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article